Literature DB >> 33084978

Sclerosing epithelioid fibrosarcoma of bone: morphological, immunophenotypical, and molecular findings of 9 cases.

Kemal Kosemehmetoglu1, Fisun Ardic2, Scott E Kilpatrick3, Ustun Aydingoz4, Vaiyapuri P Sumathi5, Michael Michal6,7.   

Abstract

Primary sclerosing epithelioid fibrosarcoma (SEF) of bone is a rare and scarcely reported neoplasm. We document clinicopathological and molecular features of 9 additional cases. Five males and 4 females had a mean age of 39 years (14-71 years). Most tumors affected flat/irregular bones; only 3 cases involved a long bone. By radiology, it has characteristic radiographic features of a predominantly lytic expansile lesion with a sclerotic rim. Referring diagnoses were SEF (n = 2), low-grade osteosarcoma (n = 2), chondrosarcoma (n = 1), and chondromyxoid fibroma (n = 1). Histologically, five cases revealed classical morphology of SEF of soft tissue. Remaining cases were classified as hybrid SEF/low-grade fibromyxoid sarcoma, characterized by spindle or stellate cells, prominent stroma, and giant hyalinized areas. Various morphological deviations such as prominent vasculature (n = 3), osteoid-like material (n = 4), or parallel bone trabeculae (n = 2) were observed. Immunohistochemically, all cases showed diffuse and strong MUC4 expression. SATB2 was observed in 5/8 cases. Using FISH, EWSR1, and FUS rearrangements were detected in 4 cases and 1 case, respectively. EWSR1-CREB3L1 fusion was identified in 1 additional case by next-generation sequencing. Recurrence and metastasis were observed in 1 case and 2 cases, respectively. All but one patient were alive with disease for a mean interval of 31 months. SEF of bone is a relatively indolent sarcoma of adults, most commonly located in the flat/irregular bones. Due to overlapping histological features, it is often misdiagnosed as osteosarcoma or a chondroid tumor. Most SEF of bone exhibit EWSR1 rearrangements, but rare cases may harbor a FUS gene fusion.

Entities:  

Keywords:  Bone neoplasm; Bone tumor; EWSR1; EWSR1-CREB3L1; FUS; MUC4; Radiology; SATB2; Sarcoma

Mesh:

Substances:

Year:  2020        PMID: 33084978     DOI: 10.1007/s00428-020-02953-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  21 in total

1.  A novel EWSR1-CREB3L1 fusion transcript in a case of small cell osteosarcoma.

Authors:  Larisa V Debelenko; Lisa M McGregor; Bangalore R Shivakumar; Howard D Dorfman; Susana C Raimondi
Journal:  Genes Chromosomes Cancer       Date:  2011-08-24       Impact factor: 5.006

2.  Metastatic Sclerosing Epithelioid Fibrosarcoma in Bone Marrow.

Authors:  Rana Asakra; Shane Zaidi; Khin Thway
Journal:  Int J Surg Pathol       Date:  2017-07-11       Impact factor: 1.271

3.  Oral and maxillofacial sclerosing epithelioid fibrosarcoma: report of five cases.

Authors:  Gretchen S Folk; Stephen B Williams; Robert B Foss; Julie C Fanburg-Smith
Journal:  Head Neck Pathol       Date:  2007-10-26

4.  Sclerosing epithelioid fibrosarcoma primary of the bone.

Authors:  Ihab Abdulkader; José Cameselle-Teijeiro; Máximo Fraga; Ana Caparrini; Jerónimo Forteza
Journal:  Int J Surg Pathol       Date:  2002-07       Impact factor: 1.271

5.  Sclerosing epithelioid fibrosarcoma of the bone: a case report of high resistance to chemotherapy and a survey of the literature.

Authors:  Thomas G P Grunewald; Irene von Luettichau; Gregor Weirich; Angela Wawer; Uta Behrends; Peter M Prodinger; Gernot Jundt; Stefan S Bielack; Reiner Gradinger; Stefan Burdach
Journal:  Sarcoma       Date:  2010-04-12

6.  MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.

Authors:  Leona A Doyle; Wei-Lien Wang; Paola Dal Cin; Dolores Lopez-Terrada; Fredrik Mertens; Alexander J F Lazar; Christopher D M Fletcher; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2012-10       Impact factor: 6.394

Review 7.  Primary sclerosing epithelioid fibrosarcoma of the sacrum: a case report and review of the literature.

Authors:  L T C Chow; Y H Lui; S M Kumta; P W Allen
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

8.  Sclerosing epithelioid fibrosarcoma of the cecum: a radiation-associated tumor in a previously unreported site.

Authors:  Jared C Frattini; Julie Ann Sosa; Susanne Carmack; Marie E Robert
Journal:  Arch Pathol Lab Med       Date:  2007-12       Impact factor: 5.534

9.  Multiple bone metastasis of sclerosing epithelioid fibrosarcoma 12 years after initial surgery-increasing ki-67 labeling index.

Authors:  Atsuko Kanno; Masahito Hatori; Masami Hosaka; Koshi N Kishimoto; Munenori Watanuki; Mika Watanabe; Eiji Itoi
Journal:  Sarcoma       Date:  2009-03-29

Review 10.  Primary sclerosing epithelioid fibrosarcoma of kidney with variant histomorphologic features: report of 2 cases and review of the literature.

Authors:  Dilek Ertoy Baydar; Kemal Kosemehmetoglu; Oguz Aydin; Julia A Bridge; Berrin Buyukeren; Fazil Tuncay Aki
Journal:  Diagn Pathol       Date:  2015-10-09       Impact factor: 2.644

View more
  1 in total

Review 1.  Metastatic pediatric sclerosing epithelioid fibrosarcoma.

Authors:  Andrew D Woods; Charles Keller; Aman Wadhwa; Reshma Purohit; Laura Crocker Mitchell; John R Collier; Katherine A Collier; Melvin Lathara; Katrina Learned; Olena Vaske; Heather Geiger; Kazimierz O Wrzeszczynski; Vaidehi Jobanputra; Ganapati Srinivasa; Erin R Rudzinski; Kimberly Whelan; Elizabeth Beierle; Sheri L Spunt
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-10-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.